CASIRIVIMAB\IMDEVIMAB for Covid-19 prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 51 adverse event reports in the FDA FAERS database where CASIRIVIMAB\IMDEVIMAB was used for Covid-19 prophylaxis.
Most Reported Side Effects for CASIRIVIMAB\IMDEVIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 875 | 20.6% | 4 | 178 |
| Dyspnoea | 687 | 16.2% | 14 | 322 |
| Nausea | 416 | 9.8% | 1 | 115 |
| Oxygen saturation decreased | 390 | 9.2% | 15 | 281 |
| Dizziness | 357 | 8.4% | 4 | 66 |
| Pyrexia | 306 | 7.2% | 4 | 146 |
| Chest discomfort | 294 | 6.9% | 0 | 44 |
| Chills | 265 | 6.2% | 4 | 107 |
| Flushing | 238 | 5.6% | 0 | 16 |
| Cough | 235 | 5.5% | 2 | 116 |
| Hypoxia | 222 | 5.2% | 8 | 184 |
| Incorrect dose administered | 220 | 5.2% | 2 | 48 |
| Hyperhidrosis | 214 | 5.0% | 4 | 51 |
| Hypotension | 211 | 5.0% | 7 | 79 |
| Chest pain | 208 | 4.9% | 1 | 73 |
Other Indications for CASIRIVIMAB\IMDEVIMAB
Covid-19 (2,943)
Product used for unknown indication (256)
Covid-19 treatment (208)
Sars-cov-2 test positive (199)
Covid-19 pneumonia (38)
Exposure to sars-cov-2 (17)
Upper respiratory tract infection (13)
Post-acute covid-19 syndrome (12)
Prophylaxis (9)
Sars-cov-2 antibody test positive (9)
Other Drugs Used for Covid-19 prophylaxis
CILGAVIMAB\TIXAGEVIMAB (1,105)
COVID-19 VACCINE NOS (583)
TOZINAMERAN (377)
ELASOMERAN (152)
ALCOHOL (136)
AZD-1222 (105)
AD26.COV2.S (64)
COVID-19 VACCINE (52)
HYDROXYCHLOROQUINE (52)
CX-024414 (50)